1-11 of 11
Robert J. Soiffer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial

Glenn J. Hanna, Roman M. Shapiro, Michal Sheffer, Michela Ansuinelli, Grace Birch, Robert A. Redd, Alejandro Alonso, Denbaa Bat-Erdene, Samantha Himberg, Heather Daley, Diego E. Hernandez-Rodriquez, Katharin L. Shaw, Jerome Ritz, Sarah Nikiforow, Robert J. Soiffer, Rizwan Romee
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PR11.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PR11
Published: 15 September 2023
View article titled, Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial
Journal Articles

Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia

Amir T. Fathi, Haesook T. Kim, Robert J. Soiffer, Mark J. Levis, Shuli Li, Annette S. Kim, Zachariah DeFilipp, Areej El-Jawahri, Steve L. McAfee, Andrew M. Brunner, Philip C. Amrein, Alice S. Mims, Laura W. Knight, Devon Kelley, AJ S. Bottoms, Lindsey H. Perry, Jonathan L. Wahl, Jennifer Brock, Elayne Breton, Dylan M. Marchione, Vincent T. Ho, Yi-Bin Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (11): 2034–2042.
https://doi.org/10.1158/1078-0432.CCR-23-0182
Published: 01 June 2023
View article titled, Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <em>IDH1</em>-Mutated Acute Myeloid Leukemia
Open the PDF for Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <em>IDH1</em>-Mutated Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Abstract 17: In situ immune expression signatures before and after ipilimumab therapy for relapsed acute myeloid leukemia after allogeneic stem cell transplantation

Pavan Bachireddy, Matthew S. Davids, Michael S. Rooney, Michaela Bowden, Chensheng W. Zhou, Scott J. Rodig, Vincent Ho, Joseph Antin, John Koreth, Edwin Alyea, Robert J. Soiffer, Catherine J. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (24_Supplement): 17.
https://doi.org/10.1158/1557-3265.HEMMAL17-17
Published: 14 December 2017
View article titled, Abstract 17: In situ immune expression signatures before and after ipilimumab therapy for relapsed acute myeloid leukemia after allogeneic stem cell transplantation
Journal Articles

Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions

Matthias Piesche, Vincent T. Ho, Haesook Kim, Yukoh Nakazaki, Michael Nehil, Nasser K. Yaghi, Dmitriy Kolodin, Jeremy Weiser, Peter Altevogt, Helena Kiefel, Edwin P. Alyea, Joseph H. Antin, Corey Cutler, John Koreth, Christine Canning, Jerome Ritz, Robert J. Soiffer, Glenn Dranoff
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1010–1018.
https://doi.org/10.1158/1078-0432.CCR-14-1956
Published: 01 March 2015
View article titled, Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
Open the PDF for Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions in another window
Includes: Supplementary data
Journal Articles

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion

Wandi Zhang, Jaewon Choi, Wanyong Zeng, Shelby A. Rogers, Edwin P. Alyea, James G. Rheinwald, Christine M. Canning, Vladimir Brusic, Tetsuro Sasada, Ellis L. Reinherz, Jerome Ritz, Robert J. Soiffer, Catherine J. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2729–2739.
https://doi.org/10.1158/1078-0432.CCR-10-0415
Published: 13 May 2010
View article titled, Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
Open the PDF for Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion in another window
Includes: Supplementary data
Journal Articles

Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes

Yishai Ofran, Haesook T. Kim, Vladimir Brusic, Loren Blake, Michael Mandrell, Catherine J. Wu, Stefanie Sarantopoulos, Roberto Bellucci, Derin B. Keskin, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1642–1651.
https://doi.org/10.1158/1078-0432.CCR-09-2701
Published: 28 February 2010
View article titled, Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes
Open the PDF for Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes in another window
Journal Articles

High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

Stefanie Sarantopoulos, Kristen E. Stevenson, Haesook T. Kim, Nazmim S. Bhuiya, Corey S. Cutler, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6107–6114.
https://doi.org/10.1158/1078-0432.CCR-07-1290
Published: 18 October 2007
View article titled, High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease
Open the PDF for High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease in another window
Journal Articles

Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8+ Immunity

Gerald P. Linette, Dongsheng Zhang, F. Stephen Hodi, Eric P. Jonasch, Simonne Longerich, Christopher P. Stowell, Iain J. Webb, Heather Daley, Robert J. Soiffer, Amy M. Cheung, Sara G. Eapen, Sharon V. Fee, Krista M. Rubin, Arthur J. Sober, Frank G. Haluska
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7692–7699.
https://doi.org/10.1158/1078-0432.CCR-05-1198
Published: 08 November 2005
View article titled, Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8<sup>+</sup> Immunity
Open the PDF for Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8<sup>+</sup> Immunity in another window
Journal Articles

Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells

Catherine J. Wu, Melinda Biernacki, Jeffery L. Kutok, Shelby Rogers, Linyun Chen, Xiao-Feng Yang, Robert J. Soiffer, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4504–4511.
https://doi.org/10.1158/1078-0432.CCR-05-0036
Published: 15 June 2005
View article titled, Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells
Open the PDF for Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells in another window
Journal Articles

Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- versus -Host Disease

Daniel J. DeAngelo, Ephraim P. Hochberg, Edwin P. Alyea, Janina Longtine, Stephanie Lee, Ilene Galinsky, Ben Parekkedon, Jerome Ritz, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5065–5071.
https://doi.org/10.1158/1078-0432.CCR-03-0580
Published: 05 August 2004
View article titled, Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: <subtitle>Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- <em>versus</em> -Host Disease</subtitle>
Open the PDF for Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: <subtitle>Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- <em>versus</em> -Host Disease</subtitle> in another window
Journal Articles

Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells

Emmanuel Zorn, Kathy S. Wang, Ephraim P. Hochberg, Christine Canning, Edwin P. Alyea, Robert J. Soiffer, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2052–2060.
Published: 01 July 2002
View article titled, Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells
Open the PDF for Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells in another window